Frédéric Delouvroy

536 total citations
5 papers, 210 citations indexed

About

Frédéric Delouvroy is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Frédéric Delouvroy has authored 5 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Frédéric Delouvroy's work include Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Frédéric Delouvroy is often cited by papers focused on Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Frédéric Delouvroy collaborates with scholars based in Sweden and Belgium. Frédéric Delouvroy's co-authors include Pierre Raboisson, Kenneth Simmen, Oliver Lenz, Tse‐I Lin, Herman de Kock, Piet Wigerinck, Katrien Vermeiren, Annick Scholliers, Bertil Samuelsson and Thierry Verbinnen and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Molecular Diversity.

In The Last Decade

Frédéric Delouvroy

5 papers receiving 204 citations

Peers

Frédéric Delouvroy
Kenny Simmen Belgium
Stacey Voss United States
Patricia McMonagle United States
John P. Maxwell United States
Per-Ola Johansson Sweden
John Tatlock United States
Anne Ekker United States
Monica Bisbocci Italy
Kathy Mosure United States
Josée Bordeleau Canada
Kenny Simmen Belgium
Frédéric Delouvroy
Citations per year, relative to Frédéric Delouvroy Frédéric Delouvroy (= 1×) peers Kenny Simmen

Countries citing papers authored by Frédéric Delouvroy

Since Specialization
Citations

This map shows the geographic impact of Frédéric Delouvroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Delouvroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Delouvroy more than expected).

Fields of papers citing papers by Frédéric Delouvroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Delouvroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Delouvroy. The network helps show where Frédéric Delouvroy may publish in the future.

Co-authorship network of co-authors of Frédéric Delouvroy

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Delouvroy. A scholar is included among the top collaborators of Frédéric Delouvroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Delouvroy. Frédéric Delouvroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
McGowan, David C., Alex De Groot, Frederik Pauwels, et al.. (2017). Synthesis and evaluation of novel HCV replication inhibitors. Molecular Diversity. 21(2). 475–481. 2 indexed citations
2.
Lin, Tse‐I, Oliver Lenz, Gregory Fanning, et al.. (2009). In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor. Antimicrobial Agents and Chemotherapy. 53(4). 1377–1385. 142 indexed citations
3.
Raboisson, Pierre, Tse‐I Lin, Herman de Kock, et al.. (2008). Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5095–5100. 18 indexed citations
4.
Nyanguile, Origène, Frederik Pauwels, Carlo Boutton, et al.. (2008). 1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors. Antimicrobial Agents and Chemotherapy. 52(12). 4420–4431. 37 indexed citations
5.
Raboisson, Pierre, Oliver Lenz, Tse‐I Lin, et al.. (2007). Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(7). 1843–1849. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenny Simmen Breakdown of academic impact, for papers by Stacey Voss Breakdown of academic impact, for papers by Patricia McMonagle Breakdown of academic impact, for papers by John P. Maxwell Breakdown of academic impact, for papers by Per-Ola Johansson Breakdown of academic impact, for papers by John Tatlock Breakdown of academic impact, for papers by Anne Ekker Breakdown of academic impact, for papers by Monica Bisbocci Breakdown of academic impact, for papers by Kathy Mosure Breakdown of academic impact, for papers by Josée Bordeleau
Rankless by CCL
2026